Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CD69 | Q07108 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PYGB | P11216 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | OGA | O60502 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12295742 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL13498558 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL15616403 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL13541586 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL14823585 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL17400176 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL14450135 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL13773326 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL20626631 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL12733141 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023242184-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS B.V. (NL) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023242194-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS B.V. (NL) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023202991-A2 | CELL-FREE ENZYMATIC METHOD FOR PREPARATION OF N-GLYCANS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-10-26 | — | — | WO | disclosed |
| EP-4265730-A1 | CELL-FREE ENZYMATIC METHOD FOR PREPARATION OF N-GLYCANS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023156349-A1 | ANTIVIRAL SULFATED CHITOSAN DERIVATIVES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2023-08-24 | — | — | WO | disclosed |
| EP-4227324-A1 | ANTIVIRAL SULFATED CHITOSAN DERIVATIVES | Consejo Superior De Investigaciones Científicas (CSIC) (ES) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022263426-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS B.V. (NL) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022263424-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS B.V. (NL) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022263406-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS B.V. (NL) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022263425-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS B.V. (NL) | 2022-12-22 | — | — | WO | disclosed |
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | disclosed |
| US-20210060169-A1 | IL-2 VARIANT | KYOWA KIRIN CO., LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| WO-2019003133-A1 | PURIFICATION OF OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2019-01-03 | — | — | WO | disclosed |
| WO-2019003135-A1 | PURIFICATION OF OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2019-01-03 | — | — | WO | disclosed |
| WO-2019003136-A1 | SYNTHESIS OF OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2019-01-03 | — | — | WO | disclosed |
| US-9878047-B2 | Prodrugs of peptide epoxy ketone protease inhibitors | ONYX THERAPEUTICS, INC. (US) | 2018-01-30 | — | — | US | disclosed |
| WO-2017046172-A1 | CARBOHYDRATE LIGANDS THAT BIND TO ANTIBODIES AGAINST GLYCOEPITOPES OF GLYCOSPHINGOLIPIDS | UNIVERSITÄT BASEL (CH) | 2017-03-23 | — | — | WO | disclosed |
| WO-2016152980-A1 | OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE CONSTRUCT USING SAME, AND METHODS FOR PRODUCING THESE | 国立大学法人岐阜大学 | 2016-09-29 | — | — | WO | disclosed |
| WO-2013166053-A2 | HOMOGENOUS AND FULLY GLYCOSYLATED HUMAN ERYTHROPOIETIN | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2013-11-07 | — | — | WO | disclosed |
| EP-2369345-A1 | Glycoconjugates and their use as potential vaccines against infection by shigella flexneri | Institut Pasteur (FR) | 2011-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210060169-A1 | IL-2 VARIANT | IL2, IL2RA, ILF2 | ALDH1A1 3896/4885THRB 1075/4885MAPK1 4056/4885 |
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | VEGFA, GUSB, NR2E3 | ALDH1A1 297/4885THRB 2211/4885MAPK1 3795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.